Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Carcinoma, Renal Cell 40Kidney Neoplasms 30Melanoma 25Prostatic Neoplasms 24Breast Neoplasms 18Wilms Tumor 16Neoplasm Metastasis 16Ovarian Neoplasms 14Carcinoma, Non-Small-Cell Lung 12Testicular Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Sarcoma 9Pancreatic Neoplasms 9Neuroblastoma 9Testicular Germ Cell Tumor 8Lymphoma, Follicular 8Lymphoma 8Lung Neoplasms 8Hodgkin Disease 8Carcinoma, Hepatocellular 8Triple Negative Breast Neoplasms 7Neoplasms, Plasma Cell 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia, Lymphocytic, Chronic, B-Cell 7

Interventions

fludarabine 1cabozantinib 1Radiotherapy 1Ifosfamide 1Filgrastim 1Doxorubicin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Cyclophosphamide × Genitourinary × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡